SPL 5.62% 9.4¢ starpharma holdings limited

Ann: VIRALEZE COVID-19 nasal spray to be ready for market Q1CY21, page-284

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 212 Posts.
    lightbulb Created with Sketch. 60
    It would be up to the tga.

    To have a punt, I suspect it will be schedule 2 meaning it can only be sold in pharmacies with limited advice/red tape required. Most other nasal sprays are schedule 2.

    unless it's considered extremely safe which is possible I doubt it would start in supermarkets. they could always start at schedule 2 or 3 and down schedule as time and evidence extends where it might land itself on the supermarket shelves.

    they might have caution advice like maximum number of sprays in a day to satisfy toxicology based on limited clinical studies from the nasal spray. hopefully fleurstat has generated significant safety data in its post market surveylance which may assist in the safety profile as it's the same active ingredient.

    bit all over the place but just my thoughts.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.4¢
Change
0.005(5.62%)
Mkt cap ! $39.30M
Open High Low Value Volume
9.0¢ 9.4¢ 9.0¢ $193.1K 2.106M

Buyers (Bids)

No. Vol. Price($)
1 174365 9.4¢
 

Sellers (Offers)

Price($) Vol. No.
9.5¢ 56056 2
View Market Depth
Last trade - 16.10pm 31/10/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.